Characteristics of Asians in the FOURIER Trial Using Evolocumab

Circ J. 2021 Oct 25;85(11):2071-2072. doi: 10.1253/circj.CJ-21-0246. Epub 2021 May 13.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized* / therapeutic use
  • Anticholesteremic Agents* / therapeutic use
  • Asian People
  • Humans

Substances

  • Antibodies, Monoclonal, Humanized
  • Anticholesteremic Agents
  • evolocumab